ADAGIO MEDICAL HOLDINGS, INC.: cash including restricted cash
Cash including restricted cash for ADAGIO MEDICAL HOLDINGS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ADAGIO MEDICAL HOLDINGS, INC. financial histories
What this measure means
Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.
Exact concept: us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 17,105,000 | USD | 2026-03-27 | 10-K · 0002006986-26-000003 |
| At date | 2024-12-31 | 20,586,000 | USD | 2026-03-27 | 10-K · 0002006986-26-000003 |
| At date | 2024-07-30 | 35,154,000 | USD | 2026-03-27 | 10-K · 0002006986-26-000003 |
| At date | 2023-12-31 | 1,383,000 | USD | 2026-03-27 | 10-K · 0002006986-26-000003 |
| At date | 2022-12-31 | 5,547,000 | USD | 2025-03-27 | 10-K · 0001558370-25-003849 |
Related financial histories
- ADAGIO MEDICAL HOLDINGS, INC.: total assets
- ADAGIO MEDICAL HOLDINGS, INC.: total liabilities
- ADAGIO MEDICAL HOLDINGS, INC.: stockholders equity
- ADAGIO MEDICAL HOLDINGS, INC.: cash and cash equivalents
- ADAGIO MEDICAL HOLDINGS, INC.: retained earnings or deficit
- ADAGIO MEDICAL HOLDINGS, INC.: net property, plant and equipment
- ADAGIO MEDICAL HOLDINGS, INC.: current assets
- ADAGIO MEDICAL HOLDINGS, INC.: current liabilities
- ADAGIO MEDICAL HOLDINGS, INC.: current accounts payable
- ADAGIO MEDICAL HOLDINGS, INC.: goodwill carrying amount
- ADAGIO MEDICAL HOLDINGS, INC.: net inventory
- ADAGIO MEDICAL HOLDINGS, INC.: common shares outstanding
- ADAGIO MEDICAL HOLDINGS, INC.: additional paid-in capital
- ADAGIO MEDICAL HOLDINGS, INC.: accumulated other comprehensive income or loss
- ADAGIO MEDICAL HOLDINGS, INC.: operating lease right-of-use asset
- ADAGIO MEDICAL HOLDINGS, INC.: long-term debt
- ADAGIO MEDICAL HOLDINGS, INC.: gross property, plant and equipment
- ADAGIO MEDICAL HOLDINGS, INC.: accumulated depreciation on property, plant and equipment
- ADAGIO MEDICAL HOLDINGS, INC.: net intangible assets excluding goodwill
- ADAGIO MEDICAL HOLDINGS, INC.: other noncurrent assets
- ADAGIO MEDICAL HOLDINGS, INC.: accrued current liabilities
- ADAGIO MEDICAL HOLDINGS, INC.: net deferred tax assets
Inspect the source
- Entity
- ADAGIO MEDICAL HOLDINGS, INC. / CIK 0002006986
- Captured
- 2026-09-21T17:42:52.193Z
- SEC response SHA-256
eb0741ca13c5d507cf2d9238a7947632ef8ec98c555ede03b5fc8021f83b1483
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0002006986.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))